Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk. - Abdu,T.A.; Elhadd,T.A.; Buch,H.; Barton,D.; Neary,R.; Clayton,R.N. (Clin Endocrinol, 2004)